STANLEY HERTZ: Open Payments
NPI 1821166158 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 42 payments from 9 companies in 2025. Trend: 2023 $938 · 2024 $744 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $260 |
| Axsome Therapeutics, Inc. | 10 | $185 |
| Corium, LLC | 8 | $112 |
| Janssen Pharmaceuticals, Inc | 2 | $69 |
| Lundbeck LLC | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Neos Therapeutics, LP | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: REXULTI, Auvelity, Azstarys, SPRAVATO, TRINTELLIX, AUSTEDO XR, EXXUA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
